Loading...
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
Nitazoxanide is a broad-spectrum antiviral agent undergoing clinical development for treatment of influenza and other viral respiratory infections. Nitazoxanide exhibits in vitro activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and other coronaviruses, inhibiting expression o...
Na minha lista:
| Udgivet i: | J Infect Public Health |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7102735/ https://ncbi.nlm.nih.gov/pubmed/27095301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2016.04.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|